Drug-induced bone disordeers;Osteopathies medicamenteuses

Journal de Radiologie

Volumn 80, Issue 7, 1999, Pages 709-713

  Javier, R M ^a   Sibilia, J ^a   Durckel, J ^a   Kuntz, J L ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Bone disorders; Drug induced; Imaging; Osteoporosis

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CHELATING AGENT; CYCLOSPORIN; FLUORINE; GLUCOCORTICOID; GONADORELIN DERIVATIVE; HEPARIN; PROTEINASE INHIBITOR; RETINOID; THYROTROPIN; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ETIDRONIC ACID; KERATOLYTIC AGENT; RETINOIC ACID; STEROID;

ALGODYSTROPHY; BONE DISEASE; DRUG INDUCED DISEASE; FLUOROSIS; FRACTURE; HUMAN; OSTEOMALACIA; OSTEOPOROSIS; RADIODIAGNOSIS; RADIOLOGIST; REVIEW; CHEMICALLY INDUCED DISORDER; RADIOGRAPHY;

ANTACIDS; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; ANTICONVULSANTS; BONE DISEASES; ETIDRONIC ACID; FLUORINE; HEPARIN; HUMANS; KERATOLYTIC AGENTS; STEROIDS; TRETINOIN;

EID: 0033158501     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Luckert BP, Raisz LG. Glucocorticoid-induced osteoporosis : pathogenesis and management. Ann Intern Med 1990; 112:352-64.
2. Adachi JD, Bensen WG, Hodsman AB. Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 1993;22:375-84.
3. Laan RFJM, Van Riel PLCM, Van De Putte LBA, Van Erning LJTO, Vant Hof MA, Lemmens JMA. Low dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis : a randomized controlled study. Ann Intern Med 1993;119:963-8.
4. Katz IA, Epstein S. Post-transplantation bone disease. J Bone Miner Res 1992;7: 123-6.
5. Epstein S. Post-transplantation bone disease : the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996;11:1-7.
6. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325:544-50.
7. Porayko MK, Wiesner RH, Hay JE et al. Bone disease in liver transplant recipients : incidence, timing and risk factors. Transplant Proc 1991;23:1462-5.
8. Jaffe MD, Willis PW. Multiple fractures associated with long term heparin therapy. JAMA 1965;193:158-60.
9. Sackler JP, Liu L. Heparin-induced osteoporosis. Br J Radiol 1973;46:548-50.
10. Griffiths HT, Liu DTY. Severe heparin osteoporosis in pregnancy. Postgrad Med J 1984;60:424-5.
11. Barbour LA, Kick SD, Steiner JF et al. A prospective study of heparin induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994;70:862-9.
12. Maillefert JF, Sibilia J, Kuntz JL, Tavernier C. Gonadotrophin releasing hormone agonists induced osteoporosis. Br J Rheumatol 1994;33:1199-200.
13. Danan S, Chaouat D, Belange G, Rascovscki T. L'ostéoporose induite par les analogues de la gonadolibérine. Rachis 1996;8:265-70.
14. Seeman E, Wahner HW, Offord KP. Differential effects of endocrine dysfunction on the axial and appendicular skeleton. J Clin Invest 1982;69:1302-9.
15. Krolner B, Vesterdal Jorgensen J, Pors Nielsen S. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone's and antithyroid treatment. Clin Endocrinol 1983;18: 439-46.
16. Hahn TJ, Avioli LV. Anticonvulsivant osteomalacia. Arch Int Med 1975;35:997-1000.
17. Hunt PA, Wuchen ML, Handal NJ et al. Bone disease induced by anticonvulsivant therapy and treatment with calcitriol. AJDC 1986;140:715-8.
18. Valimaki MJ, Tiihonen M, Laitinen K et al. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9:631-7.
19. Insogna KL, Bordley DR, Caro JF, Lockwood DH. Osteomalacia and weakness from excessive antiacid ingestion. JAMA 1980;244:2540-6.
20. Godsall JW, Baron R, Insogna KL. Vitamin D metabolism and bone histomorphometry in a patient with antiacid induced osteomalacia. Am J Med 1981; 77:744-50.
21. Charhon SA, Chavassieux PM, Chapuy MC, Boivin GY, Meunier PJ. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med 1985;106:123-31.
22. Andress DL, Maloney NA, Endres DB, Sherrard DJ. Aluminium-associated bone disease in chronic renal failure : high prevalence in a long-term dialysis population. J Bone Miner Res 1986;1: 391-8.
23. Ravault A, Meunier PJ. Suivi au long cours de 88 pagétiques traités par l'étidronate disodique en cures discontinues à faible posologie. Rev Rhum 1989;56:293-302.
24. Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT. Focal osteomalacia due to low dose diphosphonate therapy in Paget's disease. Lancet 1984;I:821-4.
25. Mautalen C, Gonzalez D, Blumenfeld EL, Santini-Araujo E, Schajowicz F. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP). Clin Orthop 1986;207:150-5.
26. Miller PD, Watts NB, Licata AA et al. Cyclical etidronate in the treatment of postmenopausal osteoporosis : efficacy and safety after seven years of treatment. Am J Med 1997;103:468-76.
27. Meunier PJ, Courpron P, Smoller JS, Briancon D. Niflumic acid-induced skeletal fluorosis : iatrogenic disease or therapeutic perspective for osteoporosis ? Clin Orthop 1980;148:304-9.
28. Prost A, Boiteau HL, Gaillard F, Hamelin JP, Carlier N, Rossel-Renac F. Ostéose fluorée secondaire à un traitement très prolongé par acide niflumique dans deux cas de polyarthrite rhumatoïde. Rev Rhum 1978;45:707-16.
29. Orcel Ph, Prier A, Crouzet J, Kaplan G. Fissures et fractures spontanées des membres inférieurs chez les ostéoporotiques traités par fluorure de sodium. Presse Med 1987;16:571-5.
30. Gerster JC, Chardon SA, Jaeger P et al. Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis. Br Med J 1983;287:723-5.
31. Bertin Ph, Clement C, Arnaud M, Treves P, Labrousse C, Desproge-Gotteron R. Fractures de contrainte au cours du traitement de l'ostéoporose par le fluorure de sodium. À propos de 9 observations et revue critique de la littérature. Rev Rhum 1990;57:151-3.
32. Pittsley RA, Yoder FN. Retinoid hyperostosis : skeletal toxicity associated with long term administration of 13-cis retinoic acid for refractory icthiosis. N Engl J Med 1983;308:1012-4.
33. Di Giovanna JJ, Helfgott RK, Gerber LH, Peck GL. Extraspinal-tendon and ligament calcification associated with long term therapy with etretinate. N Engl J Med 1986;116:207-12.
34. Goffin E, Vande Berg B, Pirson Y, Malghem J, Maldague B, Van Ypersele De Strihou C. Epiphyseal impaction as a cause of severe osteoarticular pain of lower limbs after renal transplantation. Kidney Int 1993;44:98-106.
35. Vande Berg BC, Malghem J, Goffin EJ, Duprez TP, Maldague BE. Transient epiphyseal lesions in renal transplant recipients : presumed insufficiency stress fractures. Radiology 1994;191:403-7.
36. Bouteillier G, Lloveras JJ, Condouret J, Durroux R, Durand D. Syndrome algique polyarticulaire probablement induit par la cyclosporine (SAPPIC) chez trois transplantés rénaux et un transplanté cardiaque. Rev Rhum 1989;56:753-5.
37. Mankin HJ. Non traumatic necrosis of bone. N Engl J Med 1992;326:1473-9.
38. Geusens P, Dequeker J. Locomotor side-effects of corticosteroids. Baillière's Clinical Rheumatology 1991;5:99-118.
39. Leparc JM, André T, Hélénon O, Benoit J, Paolaggi JB, Kreis H. Osteonécrose de la hanche au cours de la transplantation rénale : évolution de l'état fonctionnel et des aspects en imagerie par résonance magnétique sur trois années (trois cent cinq patients). Rev Rhum 1996;63:491-500.
40. Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS. Avascular necrosis following bone marrow transplantation. A case-control study. Bone 1998; 22:67-71.
41. Doury P. Algodystrophy. Reflex sympathetic dystrophy syndrome. Review Clin Rheumatol 1988;7:173-80.
42. Acquaviva P, Schiano A, Harnder P. Les algodystrophies : terrain et facteurs pathogéniques. Rev Rhum 1982;49: 761-66.
43. Zabraniecki L, Doub A, Mularczyk M et al. Rétraction capsulaire de l'épaule : une nouvelle complication tardive des antiprotéases ? Rev Rhum 1998;65: 80-2.